Overview

A Single Bolus of Dexmedetomidine Versus Nalbuphine in Postoperative Agitation

Status:
Recruiting
Trial end date:
2021-12-10
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is to investigate and compare the efficacy between the administrations of single intravenous (IV) dose of dexmedetomidine versus nalbuphine in preventing immediate postoperative agitation in children undergoing cleft palate repair.
Phase:
Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine
Nalbuphine